US Broker Ratings

GeneDx Holdings Corp. (WGS) Stock Analysis: A Genomics Powerhouse with a 4.29% Upside Potential

GeneDx Holdings Corp. (NASDAQ: WGS) is making significant strides in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $3.18..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Contender with a 179% Upside Potential

In the thriving sector of biotechnology, Apogee Therapeutics, Inc. (NASDAQ: APGE) has emerged as a noteworthy player, attracting investor attention with its promising pipeline and significant..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 8.41% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its extensive portfolio of biopharmaceutical assets. Based in Jupiter, Florida, Ligand develops and licenses..

LivaNova PLC (LIVN) Stock Analysis: 30.55% Potential Upside in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, is drawing significant attention from investors, with a market capitalization of $2.71 billion. Headquartered in..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a Potential 272.93% Upside in the Biotech Sector

Biohaven Ltd. (BHVN), a prominent player in the biotechnology sector, is capturing investor attention with its remarkable potential upside of 272.93%. Headquartered in New Haven, Connecticut,..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Potential 168% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company, has recently garnered attention from investors due to its promising pipeline and significant potential upside. With a current..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring a Potential 141.79% Upside for Investors

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is positioning itself as a compelling player in the biotechnology sector, focusing on the treatment of rare diseases. With a current..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Potential 95% Upside with Strong Buy Ratings

Investors seeking opportunities in the biotechnology sector might find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect, particularly with its potential upside of over 95%. As..

Twist Bioscience Corporation (TWST) Stock Analysis: Unlocking a 44.77% Potential Upside

Twist Bioscience Corporation (NASDAQ: TWST), a leading player in the Healthcare sector, specifically in Diagnostics & Research, is garnering attention with its substantial 44.77% potential upside,..

Clover Health Investments, Corp (CLOV) Investor Outlook: Exploring a Potential 47.77% Upside

Clover Health Investments, Corp (NASDAQ: CLOV), a key player in the healthcare sector, provides Medicare Advantage plans in the United States. With a market capitalization of..

Arcutis Biotherapeutics (ARQT) Stock Analysis: Unveiling a 54% Potential Upside in Biotech Innovation

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is making waves in the biotechnology industry with its focus on dermatological treatments. As a biopharmaceutical company headquartered in Westlake Village,..

Edgewise Therapeutics (EWTX) Stock Analysis: A Biotech Gem with a 195% Potential Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing investor attention with its promising pipeline of therapies designed to combat muscle disorders. As a burgeoning biopharmaceutical company based..

LeMaitre Vascular, Inc. (LMAT) Stock Report: A 13% Upside Potential Amid Robust Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is carving a niche in the medical instruments and supplies industry with its diverse portfolio of vascular surgery products. Headquartered in..

Metsera, Inc. (MTSR) Stock Analysis: A Biotech Pioneer with 90% Upside Potential

Metsera, Inc. (MTSR), a promising name in the biotechnology sector, is gaining significant attention from investors. With a market capitalization of $3.17 billion, this clinical-stage biotech..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A 42% Upside Potential in the Healthcare Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a dynamic player in the healthcare sector, is capturing investor attention with its promising pipeline and substantial upside potential. With a..

Arcellx, Inc. (ACLX) Investor Outlook: Exploring a 63.63% Potential Upside in Biotechnology

Arcellx, Inc. (NASDAQ: ACLX) has become a focal point for investors eyeing the biotechnology sector, with its innovative approach in developing immunotherapies for cancer and other..

National HealthCare Corporation (NHC) Stock Analysis: A Healthcare Player with Solid Revenue Growth and Dividend Appeal

National HealthCare Corporation (NHC) stands as a noteworthy entity within the healthcare sector, operating a comprehensive range of medical care facilities across the United States. With..

ImmunityBio, Inc. (IBRX) Stock Analysis: A Biotech Play with a Potential 361% Upside

ImmunityBio, Inc. (NASDAQ: IBRX) has captured the attention of biotech investors with its innovative approach to harnessing the body’s natural immune systems to combat cancer and..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 69.59% Upside Potential in the Medical Device Market

For investors eyeing opportunities in the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a compelling case. Specializing in cutting-edge medical devices, this company focuses on..

CG Oncology, Inc. (CGON) Stock Analysis: Unpacking a Stunning 152.43% Potential Upside

For investors with a keen eye on the biotechnology sector, CG Oncology, Inc. (NASDAQ: CGON) presents an intriguing prospect. With a current market capitalization of $1.83..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds